Relation of Fibrinogen-to-Albumin Ratio to Severity of Coronary Artery Disease and Long-Term Prognosis in Patients with Non-ST Elevation Acute Coronary Syndrome
Table 5
Evaluation of predictive models for MACE.
C-statistic
NRI
IDI
30 days
FAR
0.628 (0.560~0.696)
Established risk factors
0.706 (0.633~0.780)
Ref.
Ref.
Established risk factors + FAR
0.720 (0.647~0.793)
0.219 (-0.080~0.315)
0.084
0.005 (-0.002~0.022)
0.172
6 months
FAR
0.609 (0.556~0.661)
Established risk factors
0.650 (0.590~0.710)
Ref.
Established risk factors + FAR
0.668 (0.612~0.725)
0.155 (-0.037~0.263)
0.070
0.003 (-0.001~0.014)
0.222
1 year
FAR
0.593 (0.549~0.637)
Established risk factors
0.611 (0.561~0.661)
Ref.
Ref.
Established risk factors + FAR
0.632 (0.585~0.680)
0.136 (0.005~0.211)
0.044
0.006 (0.000~0.019)
0.042
FAR: fibrinogen-to-albumin ratio; NRI: net reclassification improvement; IDI: integrated discrimination improvement; MACE: major adverse cardiovascular event; Established risk factors included female, BMI and NSTEMI; Established risk factors included BMI and NSTEMI; Established risk factors included BMI and NSTEMI.
